Clinical trial
Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute…
NCT00389831 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00389831 |
|---|---|
| Title | Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms |
| Official title | A Randomized, Double-blind, Placebo-controlled, Parallel-group Proof-of-concept Trial to Assess the Efficacy, Safety and Tolerability of Ascending Doses of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms in Subjects With Idiopathic Restless Legs Syndrome |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug, Other |
| Interventions | Rotigotine Nasal Spray, Placebo Nasal Spray |
| Enrollment | 44 |
| Start date | Aug 1, 2006 |
| Primary completion | Nov 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Oct 19, 2006 |
| Last update posted | Oct 2, 2014 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: